(P109) Experience of People with T2D and Healthcare Providers Using Once-weekly Basal Insulin Efsitora Alfa in the QWINT Phase 3 Trials

This poster discusses a qualitative study across the QWINT-1-3 clinical trials, interviewing people with type 2 diabetes and healthcare providers to understand their experience of once-weekly basal insulin efsitora alfa. Efsitora was positively experienced, with favorable attributes including ease of use and convenience. Clinical education may help address barriers to the implementation of once-weekly efsitora.